Abstract
Enterostatin is the amino terminal pentapeptide produced by proteolytic cleavage of pancreatic procolipase and released into the small intestine during digestion of fat catalyzed by pancreatic lipase and its protein cofactor colipase. Enterostatin specifically suppresses fat intake or high-fat intake as opposed to high-carbohydrate diets. Procolipase and enterostatin have also been localized to the gastric mucosa, as well as to certain brain regions, such as amygdala, hypothalamus, and cortex. The mechanism for the decreased fat intake is dependent on cholecystokinin pathways as well as melanocortin pathways, which involves an inhibition of gastric motility in the intestine, a release of serotonin centrally and a suppression of the fat-specific hunger hormone, agouti-related peptide (AgRP). The expression of enterostatin is impaired by the presence of sucrose in the diet. Enterostatin also displays metabolic effects, such as inhibition of insulin secretion and lowering of serum cholesterol levels. Thermogenesis is likewise stimulated through an activation of sympathetic drive to brown adipose tissue with induced expression of uncoupling protein 1. The receptor for enterostatin is the β-subunit of F1-ATPase being localized to the plasma membrane in target cells. Following activation of the receptor with enterostatin various intracellular pathways are activated leading to a perturbed ATP/ADP ratio, an activation of cAMP, AMPkinase as well as MAPkinase. Enterostatin and fatty acids cause an increased expression of the receptor on the plasma membrane. No effect on food intake has been demonstrated in human beings when enterostatin is given in single doses. With green plants proteins, which induce an endogenous release of enterostatin, satiety is promoted in human beings. An enterostatin-deficient mouse has elevated plasma cholesterol levels, pointing to the role of enterostatin in reducing blood lipids. The fact that the production of enterostatin and its receptor is strongly stimulated by dietary fat suggests that enterostatin works as a feedback signal in promoting regulation of fat intake and utilization of fat as energy substrate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- α-MSH:
-
α-melanocyte-stimulating hormone
- ACTH:
-
Adrenocorticotropic hormone
- AgRP:
-
Agouti-related protein
- AMP:
-
Adenosine monophosphate
- AMPK:
-
AMPkinase
- ADP:
-
Adenosine diphosphate
- ARC:
-
Arcuate nucleus
- ATP:
-
Adenosine triphosphate
- cAMP:
-
Cyclic adenosine monophosphate
- CCK:
-
Cholecystokinin
- CNS:
-
Central nervous system
- CRH:
-
Corticotropin releasing hormone
- CSF:
-
Cerebrospinal fluid
- ERK:
-
Extracellular regulated kinase
- GLP-1:
-
Glucagon-like peptide 1
- GIP:
-
Gastrin inhibitory peptide
- 5-HT:
-
Serotonin
- MAP:
-
Kinase Mitogen activated protein kinase
- MCR:
-
Melanocortin receptor
- NMRI:
-
Naval Medical Research Institute
- NPY:
-
Neuropeptide Y
- PVN:
-
Paraventricular nucleus
- UCP:
-
Uncoupling protein
- VEGF:
-
Vascular endothelial growth factor
References
Albertsson PA, Kohnke R, Emek SC, Mei J, Rehfeld JF, Akerlund HE, et al. Biochem J. 2007;401:727–33.
Arsenijevic D, Gallmann E, Moses W, Lutz T, Erlanson-Albertsson C, Langhans W. Am J Physiol. 2005;298:E40–5.
Barton C, Lin L, York DA, Bray GA. Brain Res. 1995;702:55–60.
Berger K, Sivars U, Winzell MS, Johansson P, Hellman U, Rippe C, et al. Nutr Neurosci. 2009;297:E856–65.
Berger K, Winzell MS, Mei J, Erlanson-Albertsson C. Physiol Behav. 2004;83:623–30.
Blundell JE, Lawton CL, Halford JC. Obes Res. 1995;3 Suppl 4:471S–6.
Bouras M, Huneau JF, Luengo C, Erlanson-Albertsson C, Tome D. Peptides. 1995;16:399–405.
Bouras M, Huneau JF, Tome D. Life Sci. 1996;59:2147–55.
Bowyer RC, Jehanli AM, Patel G, Hermon-Taylor J. Clin Chim Acta. 1991;200:137–52.
Bowyer RC, Rowston WM, Jehanli AM, Lacey JH, Hermon-Taylor J. Gut. 1993;34:1520–5.
Champagne E, Martinez LO, Collet X, Barbaras R. Curr Opin Lipidol. 2006;17:279–84.
Crawley JN, Beinfeld MC. Nature. 1983;302:703–6.
Degen L, Drewe J, Piccoli F, Grani K, Oesch S, Bunea R, et al. Am J Physiol. 2007;292:R1391–9.
Dickson PR, Vaccarino F. Peptides. 1994;15:1343–52.
Duan RD, Erlanson-Albertsson C. Int J Pancreatol. 1990;6:271–9.
Duan RD, Erlanson-Albertsson C. Am J Physiol. 1992;262:G779–84.
Duncan EA, Davita G, Woods SC. Physiol Behav. 2005;85:387–93.
Erlanson-Albertsson C. Nutr Rev. 1992a;50:307–10.
Erlanson-Albertsson C. Biochim Biophys Acta. 1992b;1125:1–7.
Erlanson-Albertsson C, Hering B, Bretzel RG, Federlin K. Acta Diabetol. 1994;31:160–3.
Erlanson-Albertsson C, Larsson A. Biochimie 1988a;70:1245–50.
Erlanson-Albertsson C, Larsson A. Regulatory peptides 1988b;22:325–31.
Erlanson-Albertsson C, Mei J, Okada S, York D, Bray GA. Physiol Behav. 1991a;49:1191–4.
Erlanson-Albertsson C, Westrom B, Pierzynowski S, Karlsson S, Ahren B. Pancreas. 1991b;6:619–24.
Erlanson-Albertsson C, York D. Obes Res. 1997;5:360–72.
Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ. Am J Physiol. 2001;280:R814–21.
Halford JC, Blundell JE. Ann Med. 2000;32:222–32.
Halford JC, Cooper GD, Dovey TM. The pharmacology of human appetite expression. Curr Drug Targets. 2004;5:221–40.
Huneau JF, Erlanson-Albertsson C, Beauvallet C, Tome D. Regul Pept. 1994;54:495–503.
Imamura M, Sumar N, Hermon-Taylor J, Robertson HJ, Prasad C. Peptides. 1998;19:1385–91.
Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M. Physiol Behav. 2002;76:365–77.
Koegler FH, Schaffhauser RO, Mynatt RL, York DA, Bray GA. Physiol Behav. 1999;67:809–12.
Kohnke R, Lindbo A, Larsson T, Lindqvist A, Rayner M, Emek SC, et al. Scand J Gastroenterol. 2009a;44:712–9.
Kohnke R, Lindqvist A, Göransson N, Emek SC, Albertsson PA, Rehfeld JF, Hultgårdh-Nilsson A, Erlanson-Albertsson C. Phytother Res. 2009b;23:1778–83.
Koizumi M, Kimura S. Neurosci Lett. 2002;320:96–8.
Koizumi M, Nakanishi Y, Sato H, Morinaga Y, Ido T, Kimura S. Physiol Behav. 2002;77:5–10.
Kovacs EM, Lejeune MP, Westerterp-Plantenga MS. Br J Nutr. 2003;90:207–14.
Leibowitz SF. Ann NY Acad Sci. 1994;739:12–35.
Lin L, Bray G, York DA. Am J Physiol. 2000;278:R1346–51.
Lin L, Chen J, York DA. Peptides. 1997;18:657–61.
Lin L, Gehlert DR, York DA, Bray GA. Obes Res. 1993a;1:186–92.
Lin L, McClanahan S, York DA, Bray GA. Physiol Behav. 1993b;53:789–94.
Lin L, Okada S, York DA, Bray GA. Peptides. 1994;15:849–54.
Lin L, Park M, Hulver M, York DA. Am J Physiol. 2006;290:R909–15.
Lin L, Park M, York DA. Peptides. 2007;28:643–9.
Lin L, Thomas SR, Kilroy G, Schwartz GJ, York DA. Am J Physiol. 2003;285:R321–8.
Lin L, Umahara M, York DA, Bray GA. Peptides. 1998;19:325–31.
Lin L, York DA. Brain Res. 1997;745:205–9.
Lin L, York DA. Peptides. 1998a;19:557–62.
Lin L, York DA. Am J Physiol. 1998b;275:R619–23.
Lin L, York DA. Brain Res. 2004;1020:147–53.
Lindqvist A, Berger K, Erlanson-Albertsson C. Nutr Neurosci. 2008;11:55–60.
McCoy JG, Stump B, Avery DD. Peptides. 1990;11:221–5.
Mei J, Bouras M, Erlanson-Albertsson C. Peptides. 1997;18:651–5.
Mei J, Bowyer RC, Jehanli AM, Patel G, Erlanson-Albertsson C. Pancreas. 1993a;8:488–93.
Mei J, Cheng Y, Erlanson-Albertsson C. Int J Obes Relat Metab Disord. 1993b;17:701–4.
Mei J, Erlanson-Albertsson C. Regul Pept. 1992;41:209–18.
Mei J, Erlanson-Albertsson C. Obes Res. 1996a;4:513–9.
Mei J, Erlanson-Albertsson C. Obes Res. 1996b;4:161–5.
Mei J, Lindqvist A, Krabisch L, Rehfeld JF, Erlanson-Albertsson C. Physiol Behav. 2006;89:563–8.
Mei J, Sorhede-Winzell M, Erlanson-Albertsson C. Obes Res. 2002;10:688–94.
Miller R, DÀgostino D, Erlanson-Albertsson C, Lowe ME. Am J Physiol. 2009;297:E856–65.
Nagase H, Bray GA, York DA. Brain Res. 1997;709:44–50.
Ohinata K, Sonoda S, Shimano T, Yoshikawa M. Peptides. 2007;28:719–21.
Okada S, Lin L, York DA, Bray GA. Physiol Behav. 1993a;54:325–9.
Okada S, Onai T, Kilroy G, York DA, Bray GA. Am J Physiol. 1993b;265:R21–7.
Okada S, York DA, Bray GA. Biochem J. 1993c;292:787–9.
Okada S, York DA, Bray GA, Erlanson-Albertsson C. Physiol Behav. 1991;49:1185–9.
Okada S, York DA, Bray GA, Mei J, Erlanson-Albertsson C. Am J Physiol. 1992;262:R1111–6.
Ookuma K, Barton C, York DA, Bray GA. Peptides. 1997;18:785–91.
Ookuma M, York DA. Int J Obes Relat Metab Disord. 1998;22:800–5.
Ouagued M, Saraux B, Girard-Globa A, Bourdel G. J Nutr. 1980;110:2302–9.
Park M, Lin L, Thomas S, Braymer HD, Smith PM, Harrison DH, et al. Peptides. 2004;25:2127–33.
Park M, Lyons J, Oh H, Yu Y, Woltering EA, Greenway F, et al. Int J Obes (Lond). 2008;32:922–9.
Park M, Oh H, York DA. Peptides. 2009;30:181–90.
Prasad C, Imamura M, Debata C, Svec F, Sumar N, Hermon-Taylor J. J Clin Endocrinol Metab. 1999;84:937–41.
Pu SF, Zhuang HX, Han JS. Brain Res. 1994;657:159–64.
Rippe C, Berger K, Boiers C, Ricquier D, Erlanson-Albertsson C. Am J Physiol. 2000;279:E293–300.
Rippe C, Erlanson-Albertsson C, Lindqvist A. Brain Res. 2007;1185:152–7.
Rodriguez-Gallardo J, Silvestre RA, Marco J. Int J Obes Relat Metab Disord. 1999;23:787–92.
Rossner S, Barkeling B, Erlanson-Albertsson C, Larsson P, Wahlin-Boll E. Appetite. 1995;24:37–42.
Ruderman N, Prentki M. Nat Rev Drug Discov. 2004;3:340–51.
Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, et al. Proc Natl Acad Sci USA. 2002;99:10730–5.
Shargill NS, Tsujii S, Bray GA, Erlanson-Albertsson C. Brain Res. 1991;544:137–40.
Smith BK, York DA, Bray GA. Pharmacol Biochem Behav. 1998;60:105–14.
Sorhede M, Erlanson-Albertsson C, Mei J, Nevalainen T, Aho A, Sundler F. Peptides. 1996a;17:609–14.
Sorhede M, Mulder H, Mei J, Sundler F, Erlanson-Albertsson C. Biochim Biophys Acta. 1996b;1301:207–12.
Stanley BG, Leibowitz SF. Proc Natl Acad Sci USA. 1985;82:3940–3.
Takenaka Y, Nakamura F, Jinsmaa Y, Lipkowski AW, Yoshikawa M. Biosci Biotechnol Biochem. 2001;65:236–8.
Takenaka Y, Nakamura F, Yamamoto T, Yoshikawa M. Biosci Biotechnol Biochem. 2003;67:1620–2.
Takenaka Y, Shimano T, Mori T, Hou IC, Ohinata K, Yoshikawa M. Peptides. 2008a;29:2175–8.
Takenaka Y, Shimano T, Yamada Y, Yoshida M, Ohinata K, Yoshikawa M. Peptides. 2008b;29:559–63.
Tian Q, Nagase H, York DA, Bray GA. Obes Res. 1994;2:527–34.
White CL, Bray GA, York DA. Peptides. 2000;21:1377–81.
Winzell MS, Lowe ME, Erlanson-Albertsson C. Gastroenterology. 1998;115:1179–85.
Wu YJ, Hughes D, Lin L, Braymer DH, York DA. Peptides. 2002;23:537–44.
York DA, Lin L, Thomas SR, Braymer HD, Park M. Brain Res. 2006;1087:52–9.
Acknowledgments
My research has been carried out thanks to grants from the Swedish Medical Research Council (VR), Vinnova Foundation, Färs and Frosta Foundation, A. Påhlssons Foundation and Dr. P. Håkansson Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Erlanson-Albertsson, C. (2011). The Role of Enterostatin in Eating Behavior and Diet. In: Preedy, V., Watson, R., Martin, C. (eds) Handbook of Behavior, Food and Nutrition. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92271-3_16
Download citation
DOI: https://doi.org/10.1007/978-0-387-92271-3_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92270-6
Online ISBN: 978-0-387-92271-3
eBook Packages: MedicineMedicine (R0)